Accessibility Menu
Nukkleus logo

Nukkleus

(NASDAQ) DFNS

Current PriceN/A
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)-100%
5 YearN/A
1 Year-99%
1 Month-77%
Nukkleus last closing stock price
MetricPriceDate
Last closeUSD 0.052026-07-16
Nukkleus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-66.46%USD 0.152026-07-09
1 month-77.08%USD 0.222026-06-16
3 month-93.51%USD 0.762026-04-17
Year to date-98.78%USD 4.032025-12-31
1 year-99.38%USD 7.902025-07-16
Since inception-99.98%USD 294.482016-01-14

Nukkleus Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.65M

Net Income (TTM)

-$51.56M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Sep 2, 2026

DFNS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nukkleus

Nukkleus helps companies trade currencies and manage financial risks. It also enables easy exchange between regular money and cryptocurrencies. Soon, it plans to supply defense equipment for security systems.

Products and Services

  • FX Trading Software: Tools for retail brokers to manage foreign currency trades (majority of historical revenue).
  • Risk Management Technology: Hardware and software to help clients control trading risks.
  • Payment Services: Solutions for converting regular money to cryptocurrencies and back.
  • Customer Sales & Marketing: Services to help financial firms attract and keep clients.
  • Defense Equipment (pending): Plans to supply generators for missile defense systems after acquiring Star 26 Capital.
  • AI Simulation Access: Agreement for advanced scenario simulation tools in finance and defense.

Growth and Expansion

  • In 2025, signed to acquire 51% of Star 26 Capital, entering the defense sector.
  • In 2025, partnered with Synthetic Darwin for access to AI simulation technology.
  • Historically focused on financial technology; now shifting to defense and advanced technology markets.
  • Aligned fiscal year and reporting with Star 26 Capital for smoother integration.

What Makes Nukkleus Stand Out

Nukkleus is shifting from financial technology to defense equipment supply. Its access to advanced AI tools may support new applications in security and finance.

Five Things You Need to Know

  • Reported $0 revenue from continuing operations in Q3 2025, down 100% year-over-year.
  • All historical revenue now comes from discontinued financial services operations.
  • Net income in Q3 2025 was $3M, driven by non-cash gains.
  • Cash position was $1.52M as of June 30, 2025, with a $53.5M working capital deficit.
  • Company faces substantial doubt about its ability to continue without new financing.

Bottom Line

Nukkleus is moving from financial technology to defense supply, with no current operating revenue. Its future depends on completing acquisitions and securing new funding.

AI Generated • Apr 16, 2026

Industry

Software

Sector

Information Technology

Employees

18

CEO

Menachem Shalom, MBA

Website

www.nukk.com

Headquarters

New York, NY 10017, US

DFNS Financials

Key Financial Metrics (TTM)

Gross Margin

10.16%

Operating Margin

-955.49%

Net Income Margin

-1411.34%

Return on Equity

305.86%

Return on Capital

N/A

Return on Assets

-16.34%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-0.58%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$371.00K

Operating Income

-$34.90M

EBITDA

-$49.81M

Operating Cash Flow

-$9.78M

Capital Expenditure

-$174.78K

Free Cash Flow

-$9.96M

Cash & ST Invst.

$10.98M

Total Debt

$18.60M

Nukkleus Performance Analysis

Nukkleus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-09-30USD 21,297,642N/A
20242024-09-30USD 5,913,461-72.2%
20252025-12-31USD 0N/A
Nukkleus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Nukkleus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.19-66.1%
20232023-09-30USD -360.2730109.0%
20242024-09-30USD -4.93-98.6%
20252025-12-31USD 8.49N/A
Nukkleus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-97.0%
Q32025-09-30-474.1%
Q42025-12-31100.0%
Q12026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.65M

N/A

Gross Profit

$371.00K

N/A

Gross Margin

10.16%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

112

N/A

Net Income

-$27.15M

-126.4%

EBITDA

-$23.24M

-122.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$10.98M

+146.1%

Total Debt

$18.60M

+618.1%

Accounts Receivable

$6.09M

N/A

Inventory

$0.00

N/A

Long Term Debt

$5.97M

+488.6%

Short Term Debt

$12.64M

+701.4%

Return on Assets

-16.34%

N/A

Return on Invested Capital

-15.59%

N/A

Free Cash Flow

-$5.08M

-275.9%

Operating Cash Flow

-$4.93M

-267.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACTDArcLight Clean Transition Corp. II
$7.60-2.81%
SCLXScilex Holding Company
$8.65-1.59%
GWHESS Tech, Inc.
$0.87-1.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$67.07-0.05%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$27.44-0.00%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$42.99+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.36-0.05%

Questions About DFNS

What is the current price of Nukkleus?

Nukkleus is trading at N/A per share.

What is the 52-week range for Nukkleus?

Over the past 52 weeks, Nukkleus has traded between N/A and N/A.

How much debt does Nukkleus have?

As of the most recent reporting period, Nukkleus reported total debt of $18.60M.

How much cash does Nukkleus have on hand?

Nukkleus reported $7.70M in cash and cash equivalents in its most recent financial results.

What is Nukkleus’s dividend yield?

Nukkleus does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services